Literature DB >> 11508784

The effect of liver transplantation on circulating levels of estradiol and progesterone in male patients: parallelism with hepatopulmonary syndrome and systemic hyperdynamic circulation improvement.

R Aller1, D A de Luis, V Moreira, D Boixeda, J L Moya, C M Fernandez-Rodriguez, A L San Román, S Avila, R Bárcena.   

Abstract

The correction of hepatopulmonary syndrome (HPS) after liver transplantation (LT) remains controversial. The aims of our study were to: 1) analyze whether LT reverses HPS; 2) note any relationship between HPS and the systemic hemodynamic disturbance; and 3) note changes in circulating sex hormones and the possible association with pulmonary and systemic hemodynamic changes. Systemic hemodynamic parameters, cardiac output and systemic vascular resistance (SVR), sex hormones, and intrapulmonary vasodilatation assessed by contrast transesophageal echocardiography, and gas exchange abnormalities were investigated in 19 patients with advanced cirrhosis prior to and 6 months (176.8+/-30 days) after LT. LT was followed by a marked reduction in cardiac output (6.6+/-1.7 vs 3.5+/-0.5 l/min; p<0.001) and SVR (1039+/-460 vs 1978+/-294 dyn x sec x cm(-5); p<0.005). Before LT, circulating estradiol and progesterone levels were invariably elevated (66+/-22 pg/ml and 1.8+/-1.1 ng/ml, respectively, normal values <31 pg/ml and 0.35 ng/ml, respectively), and dropped after LT (28+/-12 pg/ml p<0.001 and 0.38+/-0.2 ng/ml; p<0.001, respectively). Seventeen of 19 patients had intrapulmonary vasodilatation and increased alveolar-arterial oxygen difference, thereby fulfilling diagnostic criteria for HPS. Patients with HPS presented higher cardiac output (p<0.05), lower SVR (p<0.01), and higher progesterone and estradiol levels than patients without HPS (p<0.05). LT produced normalization of intrapulmonary vasodilatation in all patients. LT normalized hyperdynamic circulation and is a useful therapeutic option in patients with HPS. Normalization of sex hormone levels after LT suggests that they could play a pathogenic role in the development of HPS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508784     DOI: 10.1007/BF03343883

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

Review 1.  Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation.

Authors:  M J Krowka; D A Cortese
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

2.  Progesterone and modulation of endothelium-dependent responses in canine coronary arteries.

Authors:  V M Miller; P M Vanhoutte
Journal:  Am J Physiol       Date:  1991-10

3.  Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation.

Authors:  S E Battaglia; J J Pretto; L B Irving; R M Jones; P W Angus
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

Review 4.  The hepatopulmonary syndrome.

Authors:  P A Lange; J K Stoller
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

5.  Hormonal status of postmenopausal women with alcohol-induced cirrhosis: further findings and a review of the literature.

Authors:  J S Gavaler; D H Van Thiel
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

6.  The hyperventilation of cirrhosis: progesterone and estradiol effects.

Authors:  S J Lustik; A K Chhibber; J W Kolano; I A Hilmi; L C Henson; M C Morris; O Bronsther
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

7.  Orthotopic liver transplantation in children with chronic liver disease and severe hypoxemia.

Authors:  J Hobeika; D Houssin; O Bernard; D Devictor; G Grimon; Y Chapuis
Journal:  Transplantation       Date:  1994-01       Impact factor: 4.939

8.  Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide.

Authors:  J Clària; W Jiménez; J Ros; M Asbert; A Castro; V Arroyo; F Rivera; J Rodés
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

9.  Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries.

Authors:  D R Bell; H J Rensberger; D R Koritnik; A Koshy
Journal:  Am J Physiol       Date:  1995-01

10.  Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis.

Authors:  H H Davis; D J Schwartz; S S Lefrak; N Susman; B A Schainker
Journal:  Chest       Date:  1978-04       Impact factor: 9.410

View more
  6 in total

1.  Implications of estradiol and progesterone in pulmonary vasodilatation in cirrhotic patients.

Authors:  R Aller; J L Moya; S Avila; J Villa; V Moreira; R Bárcena; D Boxeida; D A de Luis
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

Review 2.  The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.

Authors:  Samir Ahboucha; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

3.  Relevance of c-Src and protein phosphatase 2A to aromatase activity: Evidence of an acute self-regulating oestrogenic signalling complex in rat central nervous system.

Authors:  Emiliya M Storman; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neuroendocrinol       Date:  2022-01-18       Impact factor: 3.870

4.  Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study.

Authors:  Nuria Mendoza; Eva Rivas; Roberto Rodriguez-Roisin; Tamara Garcia; Miquel Bruguera; Alvar Agusti; Rosa Faner
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

5.  Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis.

Authors:  Andréa Simone Siqueira de Queirós; Simone Cristina Soares Brandão; Ana Lúcia Coutinho Domingues; Liana Gonçalves Macedo; Maira Souto Ourem; Edmundo Pessoa Almeida Lopes
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26

6.  Increased Requirement of Replacement Doses of Levothyroxine Caused by Liver Cirrhosis.

Authors:  Salvatore Benvenga; Giovanni Capodicasa; Sarah Perelli; Silvia Martina Ferrari; Poupak Fallahi; Alessandro Antonelli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-18       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.